Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
159.85
+3.74 (2.40%)
At close: Jul 28, 2026, 4:00 PM EDT
158.34
-1.51 (-0.95%)
After-hours: Jul 28, 2026, 7:16 PM EDT
Novartis AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 14,951 | 13,524 | 13,860 | 14,358 | 14,836 | 13,620 | 13,558 | 13,172 | 12,872 | 12,120 | 11,776 | 12,092 | 11,745 | 11,047 | 10,966 | 10,783 | 13,085 | 12,814 | 13,522 | 13,367 |
Revenue Growth | 0.78% | -0.70% | 2.23% | 9.00% | 15.26% | 12.38% | 15.13% | 8.93% | 9.60% | 9.71% | 7.39% | 12.14% | -10.24% | -13.79% | -18.90% | -19.33% | -1.57% | 0.95% | 3.78% | 6.61% |
Gross Profit Gross Profit Growth | 11,241 | 10,065 | 10,249 | 10,819 | 11,514 | 10,393 | 10,234 | 9,938 | 9,699 | 9,024 | 8,754 | 8,975 | 8,403 | 8,056 | 7,925 | 7,909 | 9,334 | 8,958 | 9,546 | 9,429 |
Operating Income Operating Income Growth | 4,750 | 4,235 | 3,616 | 4,501 | 4,864 | 4,663 | 3,530 | 3,627 | 4,014 | 3,373 | 2,582 | 1,762 | 2,807 | 2,618 | 1,755 | 1,826 | 2,228 | 2,852 | 2,562 | 3,233 |
Net Income Net Income Growth | 3,264 | 3,156 | 2,409 | 3,928 | 4,041 | 3,606 | 2,818 | 3,189 | 3,246 | 2,688 | 8,480 | 1,761 | 2,316 | 2,293 | 1,466 | 1,573 | 1,694 | 2,222 | 16,308 | 2,758 |
Earnings Per Share EPS Growth | 1.71 | 1.65 | 1.25 | 2.02 | 2.06 | 1.82 | 1.41 | 1.57 | 1.59 | 1.31 | 4.11 | 0.85 | 1.11 | 1.08 | 0.68 | 0.72 | 0.77 | 0.99 | 7.24 | 1.22 |
EPS Growth | -16.99% | -9.34% | -11.35% | 28.66% | 29.56% | 38.93% | -65.69% | 84.71% | 43.24% | 21.30% | 504.41% | 18.06% | 44.16% | 9.09% | -90.61% | -40.98% | -39.84% | 8.79% | 686.96% | 45.24% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cardiovascular, Renal And Metabolic Cardiovascular, Renal And Metabolic Growth | 1,688 | 1,773 | 1,601 | 2,185 | 2,655 | 2,518 | 2,403 | 2,063 | 2,080 | 2,030 | 1,758 | 1,575 | 1,594 | 1,463 | 1,333 | 1,169 | 1,147 | 1,107 | 953 | 929 |
Immunology Immunology Growth | 2,780 | 2,466 | 2,724 | 2,611 | 2,549 | 2,409 | 2,408 | 2,483 | 2,321 | 2,081 | 2,057 | 2,033 | 1,950 | 1,758 | 1,704 | 1,868 | 1,902 | 1,813 | 1,900 | 1,884 |
Neuroscience Neuroscience Growth | 1,877 | 1,561 | 1,625 | 1,609 | 1,457 | 1,302 | 1,292 | 1,225 | 1,225 | 1,008 | 996 | 1,034 | 867 | 754 | 836 | 752 | 758 | 692 | 1,286 | 1,319 |
Oncology Oncology Growth | 4,515 | 4,021 | 4,256 | 4,375 | 3,353 | 2,883 | 3,824 | 3,722 | 3,527 | 3,224 | 3,346 | 3,284 | 3,238 | 2,984 | 3,025 | 2,869 | 2,741 | 2,540 | 2,738 | 2,669 |
Established Brands Established Brands Growth | 3,548 | 3,292 | 3,130 | 3,129 | 4,040 | 4,121 | 3,226 | 3,330 | 3,359 | 3,486 | 3,266 | 3,856 | 3,788 | 3,839 | 3,678 | 3,546 | 3,651 | 3,772 | 2,970 | 2,961 |
Revenue (Total) Revenue (Total) Growth | 14,951 | 13,524 | 13,860 | 14,358 | 14,836 | 13,620 | 13,558 | 13,172 | 12,872 | 12,120 | 11,776 | 12,092 | 11,745 | 11,047 | 10,966 | 10,783 | 13,085 | 12,814 | 13,522 | 13,367 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 7,690 | 6,977 | 11,590 | 9,753 | 7,000 | 7,196 | 13,457 | 14,020 | 8,435 | 9,694 | 14,428 | 12,695 | 11,174 | 12,260 | 18,930 | 19,103 | 19,758 | 18,814 | 28,329 | 8,162 |
Total Debt Total Debt Growth | 49,014 | 46,998 | 35,457 | 32,022 | 32,637 | 31,270 | 31,401 | 32,159 | 28,987 | 27,284 | 26,439 | 25,189 | 28,340 | 29,204 | 27,964 | 28,538 | 31,087 | 31,341 | 31,093 | 34,329 |
Net Cash (Debt) Net Cash Growth | -41,324 | -40,021 | -23,867 | -22,269 | -25,637 | -24,074 | -17,944 | -18,139 | -20,552 | -17,590 | -12,011 | -12,494 | -17,166 | -16,944 | -9,034 | -9,435 | -11,329 | -12,527 | -2,764 | -26,167 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -21.59 | -20.89 | -12.37 | -11.48 | -13.08 | -12.16 | -8.95 | -8.95 | -10.04 | -8.56 | -5.82 | -6.02 | -8.19 | -7.99 | -4.20 | -4.33 | -5.12 | -5.60 | -1.23 | -11.61 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,882 | 3,676 | 2,264 | 6,571 | 6,664 | 3,645 | 4,193 | 6,286 | 4,875 | 2,265 | 2,547 | 5,378 | 3,576 | 2,957 | 4,111 | 4,721 | 3,755 | 1,649 | 3,884 | 4,925 |
Capital Expenditures CapEx Growth | -321 | -346 | -609 | -354 | -331 | -254 | -558 | -321 | -260 | -227 | -406 | -261 | -225 | -237 | -306 | -221 | -257 | -257 | -460 | -351 |
Free Cash Flow Free Cash Flow Growth | 5,561 | 3,330 | 1,655 | 6,217 | 6,333 | 3,391 | 3,635 | 5,965 | 4,615 | 2,038 | 2,141 | 5,117 | 3,351 | 2,720 | 3,805 | 4,500 | 3,498 | 1,392 | 3,424 | 4,574 |
Free Cash Flow Growth | -12.19% | -1.80% | -54.47% | 4.23% | 37.23% | 66.39% | 69.78% | 16.57% | 37.72% | -25.07% | -43.73% | 13.71% | -4.20% | 95.40% | 11.13% | -1.62% | -8.21% | -26.11% | -1.72% | 58.98% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | 75.19% | 74.42% | 73.95% | 75.35% | 77.61% | 76.31% | 75.48% | 75.45% | 75.35% | 74.46% | 74.34% | 74.22% | 71.55% | 72.92% | 72.27% | 73.35% | 71.33% | 69.91% | 70.60% | 70.54% |
Operating Margin | 31.77% | 31.31% | 26.09% | 31.35% | 32.79% | 34.24% | 26.04% | 27.54% | 31.18% | 27.83% | 21.93% | 14.57% | 23.90% | 23.70% | 16.00% | 16.93% | 17.03% | 22.26% | 18.95% | 24.19% |
Pretax Margin | 28.55% | 28.39% | 23.22% | 29.22% | 30.54% | 32.36% | 24.23% | 25.70% | 29.84% | 25.82% | 20.19% | 12.83% | 22.77% | 22.81% | 14.31% | 14.72% | 15.61% | 20.83% | 125.36% | 24.16% |
Profit Margin | 21.78% | 23.34% | 17.34% | 27.37% | 27.12% | 26.50% | 20.80% | 24.18% | 25.22% | 22.18% | 22.40% | 12.51% | 19.34% | 19.46% | 11.99% | 12.33% | 12.95% | 17.32% | 120.59% | 20.63% |
FCF Margin | 37.19% | 24.62% | 11.94% | 43.30% | 42.69% | 24.90% | 26.81% | 45.29% | 35.85% | 16.82% | 18.18% | 42.32% | 28.53% | 24.62% | 34.70% | 41.73% | 26.73% | 10.86% | 25.32% | 34.22% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | - | - | 4.666 | - | - | - | 3.862 | - | - | - | 3.919 | - | - | - | 3.461 | - | - | - | 3.401 |
Dividend Per Share Growth | - | - | 20.81% | - | - | - | -1.44% | - | - | - | 13.24% | - | - | - | 1.77% | - | - | - | - |
Dividend Yield | 0.96% | 2.13% | 0.00% | 0.00% | 1.05% | 2.43% | 0.00% | 0.00% | 1.12% | 2.63% | 0.00% | 0.00% | 0.00% | 3.95% | 0.00% | 0.00% | 0.00% | 4.06% | 0.00% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | 23.64 | 21.88 | 19.28 | 17.54 | 17.64 | 17.45 | 16.58 | 13.41 | 13.54 | 13.11 | 14.22 | 25.91 | 26.60 | 26.79 | 27.08 | 7.40 | 7.83 | 7.74 | 7.79 | 17.87 |
P/FCF Ratio | 17.77 | 16.62 | 14.95 | 12.57 | 12.12 | 12.41 | 11.83 | 15.58 | 15.49 | 15.61 | 15.40 | 13.21 | 13.74 | 12.57 | 13.66 | 12.07 | 13.55 | 13.92 | 13.21 | 12.59 |
PS Ratio | 5.25 | 5.15 | 4.64 | 4.37 | 4.24 | 4.10 | 3.72 | 4.60 | 4.41 | 4.13 | 4.42 | 4.32 | 4.43 | 3.98 | 4.19 | 3.08 | 3.31 | 3.47 | 4.21 | 3.30 |